+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Urokinase-type plasminogen activatory if effective fibrin clearance in the absence of its receptor of tissue-type plasminogen activator



Urokinase-type plasminogen activatory if effective fibrin clearance in the absence of its receptor of tissue-type plasminogen activator



Fibrinolysis 10(Suppl. 3): 79




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 034144279

Download citation: RISBibTeXText


Related references

Urokinase-type plasminogen activator is effective in fibrin clearance in the absence of its receptor or tissue-type plasminogen activator. Proceedings of the National Academy of Sciences of the United States of America 93(12): 5899-5904, 1996

Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PA. Journal of Clinical Investigation 84(2): 647-655, 1989

Differential effects of acute and chronic wound fluids on urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor, and tissue-type plasminogen activator in cultured human keratinocytes and fibroblasts. Wound Repair & Regeneration 9(4): 314-322, July-August, 2001

Urokinase-type plasminogen activator , urokinase-type plasminogen activator receptor , plasminogen activator inhibitor type 1 , type 2 , and tissue-type plasminogen activator in breast cancer cells. Fibrinolysis & Proteolysis 14(Suppl. 1): 38, 2000

Time sequence of changes in vessel wall tissue plasminogen activatory, urokinase-type plasminogen activatory and its receptor following experimental angioplasty. Fibrinolysis 10(Suppl. 3): 73, 1996

Urokinase-type plasminogen activator/type-2 plasminogen-activator inhibitor complexes are not internalized upon binding to the urokinase-type-plasminogen-activator receptor in THP-1 cells: Interaction of urokinase-type plasminogen activator/type-2 plasminogen-activator inhibitor complexes with the cell surface. European Journal of Biochemistry 233(2): 514-519, 1995

Absence of synergism between tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (scu-PA) and urokinase on clot lysis in a plasma milieu in vitro. Thrombosis and Haemostasis 56(1): 35-39, 1986

Absence of synergism between tissue type plasminogen activator single chain urokinase type plasminogen activator and urokinase on clot lysis in a plasma milieu in vitro. Thrombosis & Haemostasis 56(1): 35-39, 1986

The influence of fibrin on the kinetics of inhibition of tissue-type (T-PA) or urokinase type plasminogen activator (U-PA) by plasminogen-activator inhibitor of type 1(PAI-1) or type 2 (PAI-2). Fibrinolysis and Proteolysis 3: 38-39, 1989

Comparison of the effects of fibrinogen and fibrin products and isolated peptide chains on the fibrin mediated stimulation of plasminogen activation by tissue type plasminogen activator and on the fibrin dependent enhancement of the amidolytic activity of one chain tissue type plasminogen activator. Biological Chemistry Hoppe-Seyler 371(11): 1067-1076, 1990

Systemic administration of anti-urokinase plasminogen activator receptor monoclonal antibodies induces hepatic fibrin deposition in tissue-type plasminogen activator deficient mice. Journal of Thrombosis and Haemostasis 5(9): 1936-1944, 2007

The structure basis of the poor fibrin specificity of urokinase (II)--The inhibition of urokinase A chain 149-157 on the fibrin stimulated activation of plasminogen by tissue type plasminogen activator. Science in China. Series B, Chemistry, Life Sciences and Earth Sciences 35(8): 966-973, 1992

Nipple aspirate fluid expression of urokinase-type plasminogen activator, plasminogen activator inhibitor-1, and urokinase-type plasminogen activator receptor predicts breast cancer diagnosis and advanced disease. Annals of Surgical Oncology 10(8): 948-953, 2003

Physiological and pathological changes of plasma urokinase-type plasminogen activator, plasminogen activator inhibitor-1, and urokinase-type plasminogen activator receptor levels in healthy females and breast cancer patients. Breast Cancer Research & Treatment. 49(1): 41-50,, 1998

Expression of urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor and plasminogen activator inhibitors in patients with renal cell carcinoma: correlation with tumor associated macrophage and prognosis. Journal of Urology 174(2): 461-465, 2005